Kintor Pharmaceutical Limited

KNTPFOTCHealthcare● Active

$0.57

+$0.30(+110.58%)

Market Cap$265024496

P/E Ratio—

52W High$0.5708

52W Low$0.1774

Avg Volume256

Open$0.57

Beta-0.55

Overview

Kintor Pharmaceutical Limited (KNTPF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

KNTPF · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2025Report Date: Mar 26, 2025

EPS Actual

-$0.00

Revenue

$0.00B

Fiscal Period

Q1 FY2025

FY ends December

Report Date

Mar 26, 2025

After Market Close

KNTPF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 31, 2026	—	—	—	—	—	—
◌ Q3 FY2025	Aug 28, 2025	—	—	—	—	—	—
— Q1 FY2025	Mar 26, 2025	—	-$0.00	—	$0.00B	—	—
◌ Q1 FY2025	Mar 26, 2025	—	—	—	—	—	—
— Q3 FY2024	Aug 26, 2024	—	-$0.02	—	—	—	—
— Q3 FY2024	Aug 26, 2024	—	-$0.02	—	$0.00B	—	—
◌ Q2 FY2024	Jun 20, 2024	—	—	—	—	—	—
◌ Q1 FY2024	Mar 28, 2024	—	—	—	—	—	—

Q3 FY2026

Aug 31, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 26, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2025

Mar 26, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 26, 2024

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 26, 2024

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2024

Jun 20, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Mar 28, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2025	Mar 26, 2025	—	$0.14	$0.15	+6.18%
— Q3 FY2024	Aug 26, 2024	—	$0.08	$0.08	+0.00%
— Q3 FY2024	Aug 26, 2024	—	$0.08	$0.08	+0.00%
— Q4 FY2023	Dec 31, 2023	—	$0.17	$0.17	+0.00%
— Q3 FY2023	Aug 28, 2023	—	$0.46	$0.46	+0.00%
— Q2 FY2023	Jun 30, 2023	—	$0.47	$0.47	+0.00%

Q1 FY2025+6.18%

Report Date

Mar 26, 2025

EPS Beat/Miss

—

Price Before

$0.14

Price After

$0.15

Q3 FY2024+0.00%

Report Date

Aug 26, 2024

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.08

Q3 FY2024+0.00%

Report Date

Aug 26, 2024

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.08

Q4 FY2023+0.00%

Report Date

Dec 31, 2023

EPS Beat/Miss

—

Price Before

$0.17

Price After

$0.17

Q3 FY2023+0.00%

Report Date

Aug 28, 2023

EPS Beat/Miss

—

Price Before

$0.46

Price After

$0.46

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.47

Price After

$0.47

Beat Rate0 / 6 quarters

Largest Move+6.18% (Q1 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Kintor Pharmaceutical Limited (KNTPF) most recently reported earnings on March 26, 2025 for Q1 FY2025, posting EPS of $-0.00 (in line with the analyst consensus of —). The next KNTPF earnings date is expected around September 1, 2026.

Each quarter, investors track KNTPF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KNTPF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

KNTPF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

KNTPF earnings · 4 questions

Kintor Pharmaceutical Limited's next earnings report is expected around September 1, 2026. KNTPF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KNTPF historically reports after market close (AMC).

KNTPF earnings datewhen is KNTPF earningsKNTPF next earnings datewhen does KNTPF report earningsKNTPF earnings calendar

▸ Source: FMP · Kintor Pharmaceutical Limited SEC filings · US GAAP · Kintor Pharmaceutical Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026